First Washington Corp’s Teva Pharmaceuticals TEVA Stock Holding History

First Washington Corp’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-670	Closed	-$34K	–	81
2016 Q2	$34K	Hold	670	–	–	0.02%	72
2016 Q1	$36K	Hold	670	–	–	0.02%	68
2015 Q4	$44K	Hold	670	–	–	0.03%	69
2015 Q3	$38K	Hold	670	–	–	0.02%	79
2015 Q2	$40K	Hold	670	–	–	0.02%	79
2015 Q1	$42K	Hold	670	–	–	0.02%	72
2014 Q4	$39K	Hold	670	–	–	0.02%	74
2014 Q3	$37K	Hold	670	–	–	0.02%	79
2014 Q2	$35K	Hold	670	–	–	0.02%	95
2014 Q1	$35K	Hold	670	–	–	0.02%	96
2013 Q4	$27K	Buy	+670	New	+$26.4K	0.01%	104

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Washington Corp's TEVA Position: Q3 2016 in Review

First Washington Corp sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 670 shares — an estimated $34K sold.

First Washington Corp first reported a position in TEVA in Q4 2013 and held it in 11 quarters. The position peaked at $44K in Q4 2015. 798 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

First Washington Corp reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
First Washington Corp sold 670 Teva Pharmaceuticals shares in Q3 2016, an estimated $34K.
First Washington Corp first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 11 quarters.
First Washington Corp's Teva Pharmaceuticals position peaked at $44K in Q4 2015.
798 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on First Washington Corp's 13F filing for Q3 2016, filed 3 Nov 2016.